RASP-301

N/A

Report date: 2024/03/06 11:29:23
NMEFirst In Class

Base Information

Drug NameRASP-301
Drug Alias NameRASP-301TES-2169
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNucleophosmin inhibitors
TargetsNucleophosmin
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRasna Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRasna Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A